Florida State University College of Medicine researcher, Mohamed Kabbaj, is learning more about why the anesthetic drug Ketamine requires a higher dosage to improve depression in males than females.
FSU Researcher awarded $1.8 million to study gender differences in antidepressant effects
Published: | 12:00 am | SHARE: 
